REPORT ID 3088

EMEA (Europe, Middle East and Africa) Ophthalmic Therapeutic Drugs Market Report 2017

Publish Date
12-Dec-17
Pages
106
Format
Electronic (PDF)

In this report, the EMEA Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Ophthalmic Therapeutic Drugs for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Ophthalmic Therapeutic Drugs market competition by top manufacturers/players, with Ophthalmic Therapeutic Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer
    Pfizer
    Novartis
    ALLERGAN
    Aerie Pharmaceuticals
    Valeant Pharmaceuticals International
    Genentech
    Regeneron Pharmaceuticals
    Shire
    Santen Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    by Therapeutic Class
        Anti-inflammatory Drugs
        Anti-infective Drugs
        Anti-glaucoma Drugs
        Anti-allergy Drugs
        Anti-VEGF Agents
        Others
    by Product Type
        Prescription Drugs
        Over-the-Counter Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Ophthalmic Therapeutic Drugs Market Report 2017
1 Ophthalmic Therapeutic Drugs Overview
    1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs
    1.2 Classification of Ophthalmic Therapeutic Drugs
        1.2.1 EMEA Ophthalmic Therapeutic Drugs Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Ophthalmic Therapeutic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Anti-inflammatory Drugs
        1.2.4 Anti-infective Drugs
        1.2.5 Anti-glaucoma Drugs
        1.2.6 Anti-allergy Drugs
        1.2.7 Anti-VEGF Agents
        1.2.8 Others
    1.3 EMEA Ophthalmic Therapeutic Drugs Market by Application/End Users
        1.3.1 EMEA Ophthalmic Therapeutic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Independent Pharmacies & Drug Stores
    1.4 EMEA Ophthalmic Therapeutic Drugs Market by Region
        1.4.1 EMEA Ophthalmic Therapeutic Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Ophthalmic Therapeutic Drugs (2012-2022)
        1.5.1 EMEA Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Ophthalmic Therapeutic Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Ophthalmic Therapeutic Drugs Market Competition by Players/Manufacturers
        2.1.1 EMEA Ophthalmic Therapeutic Drugs Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Ophthalmic Therapeutic Drugs Sale Price by Players (2012-2017)
    2.2 EMEA Ophthalmic Therapeutic Drugs (Volume and Value) by Type/Product Category
        2.2.1 EMEA Ophthalmic Therapeutic Drugs Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Ophthalmic Therapeutic Drugs Sale Price by Type (2012-2017)
    2.3 EMEA Ophthalmic Therapeutic Drugs (Volume) by Application
    2.4 EMEA Ophthalmic Therapeutic Drugs (Volume and Value) by Region
        2.4.1 EMEA Ophthalmic Therapeutic Drugs Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Ophthalmic Therapeutic Drugs Sales Price by Region (2012-2017)

3 Europe Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        3.1.1 Europe Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
    3.2 Europe Ophthalmic Therapeutic Drugs Sales and Market Share by Type
    3.3 Europe Ophthalmic Therapeutic Drugs Sales and Market Share by Application
    3.4 Europe Ophthalmic Therapeutic Drugs Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Ophthalmic Therapeutic Drugs Sales Volume by Countries (2012-2017)
        3.4.2 Europe Ophthalmic Therapeutic Drugs Revenue by Countries (2012-2017)
        3.4.3 Germany Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        3.4.4 France Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        3.4.5 UK Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        3.4.6 Russia Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        3.4.7 Italy Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)

4 Middle East Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        4.1.1 Middle East Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
    4.2 Middle East Ophthalmic Therapeutic Drugs Sales and Market Share by Type
    4.3 Middle East Ophthalmic Therapeutic Drugs Sales and Market Share by Application
    4.4 Middle East Ophthalmic Therapeutic Drugs Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Ophthalmic Therapeutic Drugs Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Ophthalmic Therapeutic Drugs Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        4.4.4 Israel Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        4.4.5 UAE Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        4.4.6 Iran Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)

5 Africa Ophthalmic Therapeutic Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Ophthalmic Therapeutic Drugs Sales and Value (2012-2017)
        5.1.1 Africa Ophthalmic Therapeutic Drugs Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Ophthalmic Therapeutic Drugs Revenue and Growth Rate (2012-2017)
    5.2 Africa Ophthalmic Therapeutic Drugs Sales and Market Share by Type
    5.3 Africa Ophthalmic Therapeutic Drugs Sales and Market Share by Application
    5.4 Africa Ophthalmic Therapeutic Drugs Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Ophthalmic Therapeutic Drugs Sales Volume by Countries (2012-2017)
        5.4.2 Africa Ophthalmic Therapeutic Drugs Revenue by Countries (2012-2017)
        5.4.3 South Africa Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Ophthalmic Therapeutic Drugs Sales and Growth Rate (2012-2017)

6 EMEA Ophthalmic Therapeutic Drugs Manufacturers/Players Profiles and Sales Data
    6.1 Bayer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bayer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Novartis
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Novartis Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 ALLERGAN
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Aerie Pharmaceuticals
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Valeant Pharmaceuticals International
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Genentech
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Genentech Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Regeneron Pharmaceuticals
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Shire
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Shire Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Santen Pharmaceutical
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Ophthalmic Therapeutic Drugs Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Ophthalmic Therapeutic Drugs Manufacturing Cost Analysis
    7.1 Ophthalmic Therapeutic Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Ophthalmic Therapeutic Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Ophthalmic Therapeutic Drugs Market Forecast (2017-2022)
    11.1 EMEA Ophthalmic Therapeutic Drugs Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Ophthalmic Therapeutic Drugs Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Ophthalmic Therapeutic Drugs Price and Trend Forecast (2017-2022)
    11.2 EMEA Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Ophthalmic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Ophthalmic Therapeutic Drugs Sales Forecast by Type (2017-2022)
    11.7 EMEA Ophthalmic Therapeutic Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer